OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
AMGN
Amgen Inc.
Common Stock
280.84
1.00
0.36%
Delayed (15 Min) Trade Data: 12:00am 04/25/2025
Business Description
Not available
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0000318154
Fiscal Year End
12/31
Company Officers & Contacts
Richard Nanula
CFO
Steven M. Odre
Secretary
Board of Directors
Not available
Other Company Insiders
Not available
Service Providers
Not available
Profile Data
SIC - Industry Classification
2836 - Biological products, except diagnostic
Incorporation Information
DE, US
Employees
Not Available
Shell
No
Products and Services
Not available
Company Facilities
Not available
Company Notes
Note=2-87 State of incorporation California changed to Delaware
Formerly=Amgen to 2-87
